Response to: 'Correspondence on 'SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response'' by Westhoff et al

Ann Rheum Dis. 2021 Oct;80(10):e163. doi: 10.1136/annrheumdis-2021-220764. Epub 2021 Jul 16.
No abstract available

Keywords: COVID-19; rituximab; vaccination.

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19 Vaccines
  • COVID-19*
  • Humans
  • Immunity, Cellular
  • Rituximab
  • SARS-CoV-2*
  • Vaccination

Substances

  • COVID-19 Vaccines
  • Rituximab